Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia

Leukemia Research

Volumn 32, Issue 1, 2008, Pages 19-24

  Giovannetti, Elisa ^a   Ugrasena, Dewa G ^b   Supriyadi, Eddy ^c   Vroling, Laura ^a   Azzarello, Antonino ^a   de Lange, Desiree ^a   Peters, Godefridus J ^a   Veerman, Anjo J P ^a   Cloos, Jacqueline ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AIRLANGGA UNIVERSITY   (Indonesia)

^c GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Acute lymphoblastoid leukemia; Indonesia; Methotrexate; MTHFR C677T; Paediatric patients; TSER 2R 3R

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; ENZYME POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE; GENOTYPE; HUMAN; HUMAN TISSUE; INDONESIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; TSER GENE;

ADULT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, NEOPLASM; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDONESIA; MALE; METHOTREXATE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NETHERLANDS; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS (GENETICS); TANDEM REPEAT SEQUENCES; THYMIDYLATE SYNTHASE;

EID: 36049046978     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.02.011     Document Type: Article

References (27)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 52 (2006) 106-130
2. Pui C.H., and Evans W.E. Treatment of acute lymphoblastic leukemia. N Engl J Med 354 (2006) 166-178
3. Rots M.G., Pieters R., Kaspers G.J., Veerman A.J., Peters G.J., and Jansen G. Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia. Br J Haematol 110 (2000) 791-800
4. Ueland P.M., Hustad S., Schneede J., Refsum H., and Vollset S.E. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22 (2001) 195-201
5. Robien K., Schubert M.M., Chay T., Bigler J., Storb R., Yasui Y., et al. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation. Bone Marrow Transplant 37 (2006) 687-692
6. van Triest B., Pinedo H.M., Giaccone G., and Peters G.J. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors. Ann Oncol 11 (2000) 385-391
7. Bolufer P., Barragan E., Collado M., Cervera J., Lopez J.A., and Sanza M.A. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30 (2006) 1471-1491
8. Chiusolo P., Reddiconto G., Casorelli I., Laurenti L., Sora F., Mele L., et al. Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Ann Oncol 13 (2002) 1915-1918
9. Marsh S. Thymidylate synthase pharmacogenetics. Invest New Drugs 23 (2005) 533-537
10. Krajinovic M., Costea I., and Chiasson S. Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet 359 (2002) 1033-1034
11. Bauduer F., and Lacombe D. Factor V Leiden, prothrombin 20210A, methylene-tetrahydrofolate reductase 677T, and population genetics. Mol Genet Metab 86 (2005) 91-99
12. Marsh S., Collie-Duguid E.S., Li T., Liu X., and McLeod H.L. Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics 15 (1999) 310-312
13. de Jonge R., Hooijberg J.H., van Zelst B.D., Jansen G., van Zantwijk C.H., Kaspers G.J., et al. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in paediatric acute lymphoblastic leukemia. Blood 106 (2005) 717-720
14. Uchida K., Hayashi K., Kawakami K., Schneider S., Yochim J.M., Kuramochi H., et al. Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene. Clin Cancer Res 10 (2004) 433-439
15. Sadewa A.H., Sunarti, Sutomo R., Hayashi C., Lee M.J., Ayaki H., et al. The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population. Kobe J Med Sci 48 (2002) 137-144
16. Prasmusinto D., Skrablin S., Hofstaetter C., Fimmers R., and van der Ven K. The methylenetetrahydrofolate reductase 677 C → T polymorphism and preeclampsia in two populations. Obstet Gynecol 99 (2002) 1085-1092
17. Mutchinick O.M., Lopez M.A., Luna L., Waxman J., and Babinsky V.E. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 68 (1999) 461-467
18. Rosenberg N., Murata M., Ikeda Y., Opare-Sem O., Zivelin A., Geffen E., et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 70 (2002) 758-762
19. Lin J., and August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105 (2005) 182-192
20. Krajinovic M., Costea I., Primeau M., Dulucq S., and Moghrabi A. Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis. Pharmacogenomics J 5 (2005) 374-380
21. Krajinovic M., Lemieux-Blanchard E., Chiasson S., Primeau M., Costea I., and Moghrabi A. Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukaemia. Pharmacogenomics J 4 (2004) 66-72
22. Kumagai K., Hiyama K., Oyama T., Maeda H., and Kohno N. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Int J Mol Med 11 (2003) 593-660
23. Mauritz R., and Peters G.J. Pharmacogenetics of colon cancer and potential implications for 5-fluorouracil-based chemotherapy. Curr Pharmacogenom 4 (2006) 57-67
24. Kishi S., Griener J., Cheng C., Das S., Cook E.H., Pei D., et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 2 (2003) 3084-3091
25. Aplenc R., Thompson J., Han P., La M., Zhao H., Lange B., et al. Methylene-tetrahydrofolate reductase polymorphisms and therapy response in paediatric acute lymphoblastic leukemia. Cancer Res 65 (2005) 2482-2487
26. Taub J.W., Matherley L.H., Ravindranath Y., Kaspers G.J., Rots M.G., and Zantwijk C.H. Polymorphisms in methylenetetrahydrofolate reductase and methotrexate activity in childhood acute lymphoblastic leukemia. Leukemia 16 (2002) 764-765
27. Cole P.D., Drachtman R.A., Smith A.K., Cate S., Larson R.A., Hawkins D.S., et al. Phase II trial of oral aminopterin for adults and children with refractory acute leukemia. Clin Cancer Res 11 (2005) 8089-8096